Hemostasis and Tissue Sealing Agents Market Expected to Reach Usd 5.2 Billion Globally in 2020

Submitted by: Submitted by

Views: 10

Words: 2299

Pages: 10

Category: Business and Industry

Date Submitted: 07/29/2015 03:42 AM

Report This Essay

Transparency Market

Research

Hemostasis and Tissue Sealing Agents Market - Global

Industry Analysis, Size, Share, Growth, Trends and

Forecast 2014 - 2020

Published Date

27-01-2015

85 Page Report

Buy Now

Request Sample

Press Release

Hemostasis and Tissue Sealing Agents Market Expected to

Reach USD 5.2 Billion globally in 2020

Transparency Market Research

State Tower,

90, State Street, Suite 700.

Albany, NY 12207

United States

www.transparencymarketresearch.com

sales@transparencymarketresearch.com

Hemostasis and Tissue Sealing

Agents Market

REPORT DESCRIPTION

The hemostasis and tissue sealing agents market involves the study of wide range of hemostat,

tissue sealant and adhesion barrier products which helps the surgeons to control bleeding during

the surgery. These products play an important role in management of bleeding within the

damaged blood vessels in surgical procedures. The market of hemostasis and tissue sealing

agents is witnessing positive growth due to the introduction of technology advanced and cost

effective hemostat and tissue sealing products by key companies. For example, in June 2013,

Advance Medical Solution Group plc received approval for 2-octyl cyanoacrylate synthetic tissue

adhesive.

The company also offers wide range of hemostasis and tissue sealant products such as

RESORBA, ActivHeal and LiquiBand. Thus, wide range of product offering will boost the uptake of

these products hence drive the market growth. Other factors such as aging population and rising

number surgical procedures further drive the growth of the hemostasis and tissue sealing agents

market globally. For example, according to the World Health Organization (WHO), the number of

people aged 65 years and above is expected to increase from 605 million to 2 billion by 2050.

Aging population will boost the number of people undergoing surgical intervention which would

in turn stimulate the demand of hemostat and tissue sealing...